Skip to main content
Log in

Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): A potent inhibitor of pentagastrin-stimulated acid secretion in rats

  • Published:
Bioscience Reports

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Christiansen J, Holst JJ, Kalaja E (1976) Inhibition of gastric acid secretion in man by exogenous and endogenous pancreatic glucagon. Gastroenterology70, 688–692.

    PubMed  Google Scholar 

  2. Konturek SJ, Biernat J, Kwiecién N & Oleksy J (1975) Effect of glucagon on meal-induced gastric secretion in man. Gastroenterology68, 448–454.

    PubMed  Google Scholar 

  3. Bataille D, Gespach C, Tatemoto K, Marie J-C, Coudray A-M, Rosselin G & Mutt V (1981) Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities. Peptides2, Suppl. 2, 41–44.

    PubMed  Google Scholar 

  4. Bataille D, Tatemoto K, Coudray A-M, Carlqvist M, Rosselin G & Mutt V (1982) Isolation and chemical characterization of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum.4th Int. Symposium on Gastrointestinal Hormones, Stockholm, June 1982, in press.

  5. Bataille D, Gespach C, Coudray A-M, & Rosselin G (1981) ‘Enteroglucagon’: A specific effect on gastric glands isolated from the rat fundus. Evidence for an ‘oxyntomodulin’ action. Biosci. Rep.1, 151–155.

    PubMed  Google Scholar 

  6. Robein MJ, De La Mare M-C, Dubrasquet M & Bonfils S (1979) Utilization of the perfused stomach in anesthetized rats to study the inhibitory effect of somatostatin in gastric acid secretion. Agents Actions9, 415–421.

    PubMed  Google Scholar 

  7. Lai KS (1964) Studies of gastrin. Part 1: A method of biological assay of gastrin. Gut5, 327–333.

    Google Scholar 

  8. Gespach C, Bataille D, Dutrillaux M-C & Rosselin G (1982) The interaction of glucagon, gastric inhibitory peptide and somatostatin with cyclic AMP production systems in rat gastric glands. Biochim. Biophys. Acta720, 7–16.

    PubMed  Google Scholar 

  9. Ivey K, Tarnavski A, Sherman D, Krause WJ, Ackman K, Burks M & Hewett J (1980) Quantitative ultrastructural analysis of the human parietal cell during acid inhibtion and increase of gastric potential difference by glucagon. Gut21, 3–8.

    PubMed  Google Scholar 

  10. Wilson DE, Ginsberg B, Levine RA & Washington A (1972) Effect of glucagon on histamine-and pentagastrin-stimulated canine gastric acid secretion and mucosal blood flow. Gastroenterology61, 45–50.

    Google Scholar 

  11. Christiansen J, Bech A, Fahrenkrug J, Holst JJ, Lauritsen K, Moody AJ & Schaffalitzky de Muckadell O (1979) Fat-induced jejunal inhibiton of gastric acid secretion and release of pancreatic glucagon, enteroglucagon, gastric inhibitory polypeptide and vasoactive intestinal polypeptide in man. Scand. J. Gastroenterol.14, 161–166.

    PubMed  Google Scholar 

  12. Munck A, Bataille D, Marie JC & Rosselin G (1982) Glucagon-related peptides in human bowel: quantitative evaluation by HPLC-radioreceptor assay. Evidence for the presence of glucagon-37 (oxyntomodulin/bioactive enteroglucagon) and glucagon-29 (pancreatic glucagon).4th Int. Symposium on Gastrointestinal Hormones. Stockholm, June 1982 (in press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dubrasquet, M., Bataille, D. & Gespach, C. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): A potent inhibitor of pentagastrin-stimulated acid secretion in rats. Biosci Rep 2, 391–395 (1982). https://doi.org/10.1007/BF01119301

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01119301

Keywords

Navigation